SNAI2 and non-small cell lung carcinoma: To further clarify the role of SNAI2/SLUG in lung cancer and in particular in the advanced setting, this study was conducted to examine the correlation with hormone receptor expression as well as different MMP along with the clinical outcome in Western patients with metastatic NSCLC, enrolled in a randomized first-line chemotherapy trial.